The “3D Cell Culture Technologies Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.
The global 3D cell culture technologies market is expected to grow from $1.63 billion in 2020 to $1.88 billion in 2021 at a compound annual growth rate (CAGR) of 15.3%. The market is expected to reach $4.23 billion in 2025 at a CAGR of 22.5%.
Major players in the 3D cell culture technologies market are Nano3D Biosciences Corning Inc., Merck & Co., 3D Biotek LLC, 3D Biomatrix and Thermo Fisher Scientific.
The 3D cell culture technologies market consist of sales of 3D cell culture technologies and related services. Some of the 3D cell culture technologies include microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. The 3D cell culture technologies market does not include sales of cell culture consumables and instruments. This market is segmented into scaffold based, scaffold-free technologies and 3D bioreactors.
The possibility of contaminating the cells is restricting the 3D Cell Culture technologies market. Contamination of the cell culture refers to the presence of bacteria, moulds, yeasts, viruses, and mycoplasma that can adversely affect the cell culture. Contamination usually occurs when the cells are mishandled or due to the lack of adequate care, as a result the process of regeneration may get affected.
According to a study conducted by Yale and Tuff’s university, it was found that 3D cultures are more complex than 2D cell cultures and they require a more controlled cellular environment in order to mimic structures for tissue or organ transplants. Therefore, probability of cell culture contamination is relatively higher in 3D cell cultures.
Implementing the latest technology is the latest trend in the 3D Cell culture market. For example, various companies have adopted one such advancement into the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism.
This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek’s 3D cell expansion system to be used as a medical device. It also approved Biotek’s Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA approved implants and drug delivery devices.
In 2018, Greiner Bio-One North America Inc. acquired 3D cell culture technology platform of Nano 3D Biosciences Inc. for an undisclosed amount. This will not only help Greiner Bio-One expand its portfolio but it will also help it strengthen its reach in the market. 3D cell culture is a disruptive technology in this market, it will help by improving the quality of results and pave new pathways towards disease treatment and prevention. Nano 3D Biosciences was established in 2008 and is headquartered in Texas, USA.
The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation.
FDA regulates the cell culture technologies under title 21, sec 864.2240. FDA states that cell and tissue culture technologies should be labelled or mentioned as sterile, or else they would be removed from the good manufacturing practice of the quality system. Each technology unit should maintain procedures to receive, review, and evaluate complaints. These procedures should also include the consistent documentation of the receipts.
Key Topics Covered:
1. Executive Summary
2. 3D Cell Culture Technologies Market Characteristics
3. 3D Cell Culture Technologies Market Trends and Strategies
4. Impact Of COVID-19 On 3D Cell Culture Technologies
5. 3D Cell Culture Technologies Market Size and Growth
5.1. Global 3D Cell Culture Technologies Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global 3D Cell Culture Technologies Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. 3D Cell Culture Technologies Market Segmentation
6.1. Global 3D Cell Culture Technologies Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
6.2. Global 3D Cell Culture Technologies Market, Segmentation by End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Research Laboratories and Institutes
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Centers
- Other End Users
6.3. Global 3D Cell Culture Technologies Market, Segmentation by Scaffold-based, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Polymeric scaffolds
- Micropatterned Surface Microplates
6.4. Global 3D Cell Culture Technologies Market, Segmentation by Scaffold-free, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Hanging drop microplates
- Spheroid microplates
- Microfluidic 3D cell culture
- Magnetic levitations & 3D bioprinting
6.5. Global 3D Cell Culture Technologies Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Cancer Research
- Stem Cell Research
- Drug Discovery
- Regenerative Medicine
7. 3D Cell Culture Technologies Market Regional and Country Analysis
7.1. Global 3D Cell Culture Technologies Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global 3D Cell Culture Technologies Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Becton Dickinson & Co
- Corning Incorporation
- GE Healthcare
- Merck KGaA
- Thermo Fisher Scientific
- HiMedia Laboratories
- Agilent Technologies
- PromoCell GmbH
- CellGenix GmbH
- Greiner Bio-One
- Irvine Scientific
- Cell Culture Company (CCC) LLC
- Sera Care Life Sciences Incorporation
- American Type Culture Collection
- Miltenyi Biotec
- Sumitomo Bakelite
- EMD Millipore
- Affymetrix Inc
- VWR International
- WHEATON IndustriesInc
- Sartorius AG
For more information about this report visit https://www.researchandmarkets.com/r/5sedor
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900